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Dear Editor-in-Chief  
 
Osteoporosis is a skeletal system disease 
diagnosed following a reduction in bone mass 
density. Osteoporosis is an important cause of 
bone fractures. It can also increase hospitaliza-
tions due to secondary complications and is an 
important threat to the life of older adults (1). 
According to the latest statistics published in 
Iran, the overall prevalence of osteoporosis is 
17%. This prevalence was reported as 12% in 
men and as 19% in post-menopausal women. 
Approximately 35% of the adult and older adult 
population of the country is affected by osteo-
penia (2). Furthermore, about two million people 
are at risk for osteoporotic fractures in Iran (3).  
Osteoporosis is an important problem among the 
older adult population, and this issue is further 
exacerbated by the higher life expectancy and 
consequently the increased older adult population 
in Iran. According to WHO, life expectancy was 
74.77 yr in 2015 (4), 71.9 yr for men and 78 yr for 
women (5). This index is indicative of population 
aging in Iran. The prevalence of osteoporosis as a 
prevalent disease among older adults is expected 
to further increase in Iran in the future and may 
become a detrimental threat to the health and life 
of Iranian older adults. 
The direct costs of osteoporotic hip fractures were 
28 million USD in 2010 in Iran and these costs are 
expected to reach 51 and 250 million USD by 
2020 and 2050 (3). Osteoporosis is a largely pre-
ventable disease associated with major controllable 
risk factors such as poor nutrition, smoking, low 
physical activity and the abuse of corticosteroids 
(1). The consumption of milk and dairy products 
as an important factor in helping prevent osteopo-
rosis is half its global standard in Iran. The annual 
per capita consumption of dairy should be about 
165 kg; however, this figure is approximately 85 kg 
in Iran (6). Moreover, the prevalence of vitamin D 
deficiency as another risk factor for osteoporosis 
was reported as 10% to 50% in Iran (7-9). 
Given the existing evidence on osteoporosis and 
its risk factors in Iran and the phenomenon of 
population aging in the country, osteoporosis is 
expected to affect a large proportion of the Irani-
an population in the years to come. The facts 
about the disease in Iran can be an alarm for 
health policymakers. Planning for primary pre-
ventive actions for osteoporosis is therefore es-
sential for improving the health and quality of life 
of the Iranian population, especially its older 
adult population.  
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